25
Participants
Start Date
June 26, 2023
Primary Completion Date
December 6, 2024
Study Completion Date
February 18, 2025
OTOV101N+OTOV101C Injections
The gene therapy of OTOV101N+OTOV101C injection via intracochlear injection.
RECRUITING
Shandong Second Provincial General Hospital, Jinan
NOT_YET_RECRUITING
Beijing Tongren Hospital, Beijing
NOT_YET_RECRUITING
Beijing Union Hospital, Beijing
NOT_YET_RECRUITING
Chinese PLA Genreal Hospital, Beijing
NOT_YET_RECRUITING
The Third Bethune Hospital of Jilin University, Changchun
NOT_YET_RECRUITING
The Second Xiangya Hospital of Central South University, Changsha
NOT_YET_RECRUITING
Sichuan Provincial People Hospital, Chengdu
NOT_YET_RECRUITING
Chongqing Municipal People Hospital, Chongqing
NOT_YET_RECRUITING
The First Affiliated Hospital of Fujian Medical University, Fuzhou
NOT_YET_RECRUITING
Guangdong Provincial People Hospital, Guangzhou
NOT_YET_RECRUITING
The First Affiliated Hospital of Harbin Medical University, Harbin
NOT_YET_RECRUITING
The First Affiliated Hospital of USTC, Hefei
NOT_YET_RECRUITING
The Second Affiliated Hospital of Anhui Medical University, Hefei
NOT_YET_RECRUITING
Yunnan Provincial First People Hospital, Kunming
NOT_YET_RECRUITING
Dongnan University Zhongda Hospital, Nanjing
RECRUITING
Nanjing Drum Tower Hospital, Nanjing
NOT_YET_RECRUITING
The Second Hospital of Ningbo, Ningbo
NOT_YET_RECRUITING
Shengjing Hospital Of China Medical University, Shenyang
NOT_YET_RECRUITING
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
RECRUITING
Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Zhongnan Hospital of Wuhan University, Wuhan
NOT_YET_RECRUITING
Xijing Hospital, Xi'an
NOT_YET_RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Lead Sponsor
Otovia Therapeutics
INDUSTRY